Learn about the flu shot, COVID-19 vaccine, and our masking policy »
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Get the iPhone MyHealth app »
Get the Android MyHealth app »
Abstract
Tie2 promoter-mediated loss of peroxisome proliferator-activated receptor gamma (PPAR?) in mice leads to osteopetrosis and pulmonary arterial hypertension. Vascular disease is associated with loss of PPAR? in pulmonary microvascular endothelial cells (PMVEC), we evaluated the role of PPAR? in PMVEC functions, such as angiogenesis and migration. The role of PPAR? in angiogenesis was evaluated in Tie2CrePPAR?(flox/flox) and wild type (WT) mice, and in mouse and human PMVECs. RNA-sequencing and bioinformatic approaches were utilized to reveal angiogenesis-associated targets for PPAR?. Tie2CrePPAR?(flox/flox) mice showed an impaired angiogenic capacity. Analysis of endothelial progenitor-like cells using bone marrow transplantation combined with evaluation of isolated PMVECs revealed that loss of PPAR? attenuates the migration and angiogenic capacity of mature PMVECs. PPAR?-deficient human PMVECs showed a similar migration defect in culture. Bioinformatic and experimental analyses revealed E2F1 as a novel target of PPAR? in the regulation of PMVEC migration. Disruption of the PPAR?-E2F1 axis was associated with a dysregulated Wnt pathway related to the GSK3ß interaction protein. In conclusion, PPAR? plays an important role in sustaining angiogenic potential in mature PMVECs through E2F1-mediated gene regulation.
View details for DOI 10.1242/jcs.169011
View details for Web of Science ID 000370240900006